Literature DB >> 15125742

The optimal number of sentinel lymph nodes for focused pathologic examination.

David J Dabbs1, Ronald Johnson.   

Abstract

The sentinel lymph node (SLN) procedure provides an alternative method for assessing the axillary lymph nodes in patients with breast cancer. The SLN is typically subjected to a focused pathologic examination involving the examination of multiple tissue levels and/or keratin immunohistology. The number of SLNs submitted may vary widely, in some cases rivaling that of a complete axillary dissection (CAD). We examined our experience over the last 2 years in order to determine the optimal number of SLNs for focused pathologic evaluation. All SLN cases for the years 2000 and 2001 were retrieved from the files of the Pathology Department at Magee-Womens Hospital and were tabulated to determine the average number of SLNs per case, the number of SLNs submitted, the actual SLN that was positive for each case, the type of metastasis, and the average number of SLNs per case for each surgeon. There were 662 operative cases that yielded 1576 SLN accessions and 1758 total SLNs. The range of SLNs submitted was 1 to 11. Overall there was a mean of 2.4 SLNs accessioned per case and a mean of 2.7 SLNs per case. A study of the statistics of SLNs submitted by seven surgeons yielded two distinct groups, with one group submitting virtually all of the cases where there were consistently more than four SLNs per case. Ninety-seven percent of positive SLNs were discovered in the first three SLNs submitted, regardless of surgeon identity. The SLNs beyond numbers one to three yielded positive results by keratin in only four cases. Focused pathologic examination of SLNs was most effective for the first three SLNs submitted for any given case. The variation in the number of SLNs submitted per case was different based upon the different practice patterns of surgeons. It is suggested that for more than three SLNs submitted, simple routine lymph node examination would be appropriate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15125742     DOI: 10.1111/j.1075-122X.2004.21283.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  4 in total

1.  Predictors of nonsentinel nodal involvement to aid intraoperative decision making in breast cancer patients with positive sentinel lymph nodes.

Authors:  Ern Yu Tan; Bernard Ho; Juliana J C Chen; Pey Woei Ho; Christine Teo; Arul Earnest; Patrick M Y Chan
Journal:  ISRN Oncol       Date:  2011-08-16

2.  How many sentinel lymph nodes are enough for accurate axillary staging in t1-2 breast cancer?

Authors:  Eun Jeong Ban; Jun Sang Lee; Ja Seung Koo; Seho Park; Seung Il Kim; Byeong-Woo Park
Journal:  J Breast Cancer       Date:  2011-12-27       Impact factor: 3.588

3.  Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery.

Authors:  Stephen P Povoski; Donn C Young; Michael J Walker; William E Carson; Lisa D Yee; Doreen M Agnese; William B Farrar
Journal:  World J Surg Oncol       Date:  2007-02-09       Impact factor: 2.754

4.  Comparison of [(99m)Tc]tilmanocept and filtered [(99m)Tc]sulfur colloid for identification of SLNs in breast cancer patients.

Authors:  Jennifer L Baker; Minya Pu; Christopher A Tokin; Carl K Hoh; David R Vera; Karen Messer; Anne M Wallace
Journal:  Ann Surg Oncol       Date:  2014-07-29       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.